Based on the synergistic reduction of tumor growth of ATM inhibitor AZD0156 and ATR inhibitor VE-822 with a single dose of 1 × 2 Gy13, we first aimed to enhance this effect with a more clinically relevant RT scheme. Here, ATR is linked to neoplasm.